Recombinant, octavalent group A streptococcal M protein vaccine

Vaccine

Volumn 14, Issue 10, 1996, Pages 944-948

  Dale, James B ^a   Simmons, Matthew ^a,b,c   Chiang, Elbert C ^a,b   Chiang, Edna Y ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^c UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

M protein; Opsonic antibodies; Streptococcus pyogenes; Vaccine

Indexed keywords

CROSS REACTING ANTIBODY; FREUND ADJUVANT; HYBRID PROTEIN; M PROTEIN; RECOMBINANT VACCINE; STREPTOCOCCUS VACCINE;

AMINO TERMINAL SEQUENCE; ANIMAL EXPERIMENT; ARTICLE; GENE SEQUENCE; IMMUNE RESPONSE; IMMUNOGENICITY; NONHUMAN; OPSONIZATION; PRIORITY JOURNAL; PROTEIN CONFORMATION; RABBIT; SEROTYPE; STREPTOCOCCUS GROUP A;

EID: 0030197916     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0264-410X(96)00050-3     Document Type: Article

References (42)

1. 1 Stevens, D.L., Tanner, M.H., Winship, J. et al. Severe group A streptococcal infections associated with a toxic shock-like syndrome and scarlet fever toxin A. N. Engl. J. Med. 1989, 321, 1-7
2. 2 Land, M.A. and Bisno, A.L. Acute rheumatic fever: a vanishing disease in suburbia. J. Am. Med. Assoc. 1983, 249, 895-899
3. 3 Veasey, L.G., Wiedneier, S.W., Osmond, G.S. et al. Resurgence of acute rheumatic fever in the intermountain region of the United States. N. Engl. J. Med. 1987, 316, 421-427
4. 4 Kass, E.H. Infectious diseases and social change. J. Infect. Dis. 1971, 123, 100-109
5. 5 Community control of rheumatic heart disease in developing countries. (1): a major public health problem. WHO Chronicle 1980, 34, 336-345
6. 6 Bessen, D. and Fischetti, V.A. Influence of intranasal immunization with synthetic peptides corresponding to conserved epitopes of M protein on mucosal colonization by group A streptococci. Infect. Immun. 1988, 56, 2666-2672
7. 7 Bronze, M.S., Courtney, H.S. and Dale, J.B. Epitopes of group A streptococcal M protein that evoke cross-protective local immune responses. J. Immun. 1992, 148, 888-893
8. 8 Kapur, V., Maffei, J.T., Greer, R.S., Li, L.L., Adams, G.J. and Musser, J.M. Vaccination with extracellular cysteine protease (interleukin 1B convertase) protects mice against challenge with heterologous group A streptococci. Microb. Pathogen. 1994, 16, 443-450
9. 9 Salvadori, L.G., Blake, M.S., McCarty, M., Tai, J.Y., Zabriskie, J.B. Group A streptococcus-liposome ELISA antibody titers to group A polysaccharide and opsonophagocytic capabilities of the antibodies. J. Infect. Dis. 1995, 171, 593-600
10. 10 Ji, Y., McLandsborough, L., Kondagunta, A. and Cleary, P.P. C5a peptidase alters clearance and trafficking of group A streptococci by infected mice. Infect. Immun. 1995, 64, 503-510
11. 11 Lancefield, R.C. Current knowledge of the type specific M antigens of group A streptococci. J. Immun. 1962, 89, 307-313
12. 12 Lancefield, R.C. Persistence of type-specific antibodies in man following infection with group A streptococci. J. Exp. Med. 1959, 110, 271-283
13. 13 Dale, J.B. and Beachey, E.H. Protective antigenic determinant of streptococcal M protein shared with sarcolemmal membrane protein of human heart. J. Exp. Med. 1982, 156, 1165-1176
14. 14 Dale, J.B. and Beachey, E.H. Multiple heart-cross-reactive epitopes of streptococcal M proteins. J. Exp. Med. 1985, 161, 113-122
15. 15 Baird, R.W., Bronze, M.S., Kraus, W., Hill, H.R., Veasey, L.G. and Dale, J.B. Epitopes of group A streptococcal M protein shared with antigens of articular cartilage and synovium. J. Immun. 1991, 146, 3132-3137
16. 16 Bronze, M.S. and Dale, J.B. Epitopes of streptococcal M proteins that evoke antibodies that cross-react with human brain. J. Immun. 1993, 151, 2820-2828
17. 17 Cunningham, M.W. and Russell, S.M. Study of heart-reactive antibody in antisera and hybridoma culture fluids against group A streptococci. Infect Immun. 1983, 42, 531-538
18. 18 Beachey, E.H., Seyer, J.M., Dale, J.B., Simpson, W.A. and Kang, A.H. Type-specific, protective immunity evoked by a synthetic peptide of Streptococcus pyogenes M protein. Nature (London). 1981, 292, 457-459
19. 19 Beachey, E.H. and Seyer, J.M. Protective and nonprotective epitopes of chemically synthesized peptides of the NH2-terminal region of type 6 streptococcal M protein. J. Immun. 1986, 136, 2287-2292
20. 20 Dale, J.B., Seyer, J.M. and Beachey, E.H. Type-specific immunogenicity of a chemically synthesized peptide fragment of type 5 streptococcal M protein. J. Exp. Med. 1983, 158, 1727-1732
21. 21 Dale, J.B. and Beachey, E.H. Localization of protective epitopes of the amino terminus of type 5 streptococcal M protein. J. Exp. Med. 1986, 163, 1191-1202
22. 22 Dale, J.B., Chiang, E.Y and Lederer, J.W. Recombinant tetravalent group A streptococcal M protein vaccine. J. Immun. 1993, 151, 2188-2194
23. 23 Dale, J.B. and Chiang, E.C. Intranasal immunization with recombinant group a streptococcal M protein fragment fused to the B subunit of Escherichia coli labile toxin protects mice against systemic challenge infections. J. Infect. Dis. 1995, 171, 1038-1041
24. 24 Haanes-Fritz, E., Kraus, W., Burdett, V., Dale, J.B. and Beachey, E.H. Comparison of the leader sequences of four group A streptococcal M protein genes. Nucleic Acids Res. 1988, 16, 4667-4677
25. 25 Bessen, D.E. and Fischetti, V.A. Nucleotide sequences of two adjacent M or M-like protein genes of group A streptococci: different RNA transcript levels and identification of a unique immunoglobulin A-binding protein. Infect. Immun. 1992, 60, 124-135
26. 26 Mouw, A.R., Beachey, E.H. and Burdett, V. Molecular evolution of streptococcal M protein: cloning and nucleotide sequence of the type 24 M protein gene and relation to other genes of Streptococcus pyogenes. J. Bacteriol. 1988, 170, 676-684
27. 27 Miller, L., Gray, L., Beachey, E.H. and Kehoe, M. Antigenic variation among group A streptococcal M proteins: nucleotide sequence of the serotype 5 M protein gene and its relationship with genes encoding types 1, 6 and 24 M proteins. J. Biol. Chem. 1988, 263, 5668-5673
28. 28 Hollingshead, S.K., Fischetti, V.A. and Scott, J.R. Complete nucleotide sequence of type 6 M protein of the group A streptococcus. Repetitive structure and membrane anchor. J. Biol. Chem. 1986, 261, 1677-1686
29. 29 Dale, J.B., Washburn, R.G., Marques, M.B and Wessels, M.R. Hyaluronate capsule and surface M protein in resistance to opsonization of group A streptococci. Infect. Immun. 1996, 64, 1495-1501
30. 30 Podbielski, A., Melzer, B. and Lutticken, R. Application of the polymerase chain reaction to study the M protein (-like) gene family in B-hemolytic streptococci. Med. Microbiol. Immun. 1991, 180, 213-219
31. 31 Sanger, F., Nicklen, S. and Coulson, A.R. DNA sequencing with chain-terminating inhibitors. Proc. Natl Acad. Sci. USA 1977, 74, 4767-4771
32. 32 Beachey, E.H., Stollerman, G.H., Chiang, E.Y., Chiang, T.M., Seyer, J.M. and Kang, A.H. Purification and properties of M protein extracted from group A streptococci with pepsin: covalent structure of the amino terminal region of the type 24 M antigen. J. Exp. Med. 1977, 145, 1469-1483
33. 33 Dale, J.B., Ofek, I. and Beachey, E.H. Heterogeneity of type-specific and cross-reactive antigenic determinants within a single M protein of group A streptococci. J. Exp. Med. 1980, 151, 1026-1038
34. 34 Kraus, W., Haanes-Fritz, E., Cleary, P.P., Seyer, J.M., Dale, J.B. and Beachey, E.H. Sequence and type-specific immunogenicity of the amino-terminal region of type 1 streptococcal M protein. J. Immun. 1987, 139, 3084-3090
35. 2-terminal sequences of types 5, 6, and 24 M proteins synthesized in tandem. J. Exp. Med. 1987, 166, 647-656
36. 36 Jones, K.F., Manjula, B.N., Johnston, K.H., Hollingshead, S.K., Scott, J.R. and Fischetti, V.A. Location of variable and conserved epitopes among the multiple serotypes of streptococcal M protein. J. Exp. Med. 1985, 161, 623-628
37. 37 Johnson, D.R., Stevens, D.L. and Kaplan, E.L. Epidemiologic analysis of group A streptococcal serotypes associated with severe systemic infection, rheumatic fever, or uncomplicated pharyngitis. J. Infect. Dis. 1992, 166, 374-382
38. 38 Martin, D.R., Voss, L.M., Walker, S.J. and Lennon, D. Acute rheumatic fever in Auckland, New Zealand: spectrum of associated group A streptococci different from expected. Pediatr. Infect. Dis. J. 1994, 13, 264-269
39. 39 Stollerman, G.H. Rheumatogenic group A streptococci and the return of rheumatic fever. Adv. Intern. Med. 1990, 35, 1-26
40. 40 Martin, D.R. and Single, L.A. Molecular epidemiology of group A streptococcus M type 1 infection. J. Infect. Dis. 1993, 167, 1112-1117
41. 41 Musser, J.M., Kapur, V., Szeto, J., Pan, X., Swanson, D.S. and Martin, D.R. Genetic diversity and relationships among Streptococcus pyogenes strains expressing serotype M1 protein: recent intercontinental spread of a subclone causing invasive disease. Infect. Immun. 1995, 63, 994-1003
42. 42 de Malmanche, S.A. and Martin, D.R. Protective immunity to the group A streptococcus may be only strain specific. Med. Microbiol. Immun. 1994, 183, 299-306